Browse by Journal Title

Article

Platelet inhibition: new agents, new strategies, new trials.
Gulba, D.C. and Huber, K. and Moll, S. and Dietz, R.
Fibrinolysis & Proteolysis 12 (Suppl 2): 13-23. 1 September 1998

Acute coronary syndromes: recent achievements and future aspects.
Huber, K. and Nikfardjam, M. and Christ, G. and Gottsauner-Wolf, M. and Muellner, M. and Gulba, D.
Fibrinolysis & Proteolysis 12 (Suppl 2): 67-89. 1 September 1998

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans.
Gulba, D.C. and Praus, M. and Dechend, R. and Hauck, S. and Mahler, M. and Zitvz, R. and Baldus, B. and Mueller, W. and Dietz, R.
Fibrinolysis & Proteolysis 11 Suppl. 2 : 55-62. 1 August 1997

Signal transduction via urokinase receptor: is a transmembrane adapter molecule really necessary?
Dumler, I. and Hucho, F. and Gulba, D.
Fibrinolysis & Proteolysis Suppl. 11 : 165-169. 1 January 1997

New antithrombotic agents: an overview.
Windstetter, U. and Huber, K. and Gulba, D.
Fibrinolysis & Proteolysis 11 Suppl. : 85-96. 1 January 1997

The problem of reocclusion and restenosis - clinical aspects.
Dechend, R. and Gulba, D. and Hauck, S. and Dietz, R.
Fibrinolysis & Proteolysis 9 (Suppl:1): 48-52. 1 January 1995

DSPA alpha - properties of the plasminogen activators of the vampire bat desmodus rotundus.
Gulba, D. and Praus, M. and Witt, W.
Fibrinolysis & Proteolysis 9 (Suppl:1): 91-96. 1 January 1995

Nierenarterien-Embolie - Thrombloyse mit rt-RA.
Gulba, D.C.
Fibrinolysis & Proteolysis 3 : 15-17. 1 January 1995

Continuous 3-dimensional vectorcardiography, a valuable tool for online ischemia monitoring.
Hauck, S. and Friedrich, M. and Dechend, R. and Gulba, D. and Dietz, R.
Fibrinolysis & Proteolysis 9 (Suppl:1): 114-120. 1 January 1995

Thrombolysis - a rapidly moving target of antithrombotic therapy: a preface.
Huber, K. and Bode, C. and Gulba, D.
Fibrinolysis & Proteolysis 9 (Suppl:1): 1-2. 1 January 1995

Prevention of postoperative thromboembolic complications in a patient with budd-chiari syndrome and acquired protein c deficiency by short-term administration of protein c concentrates.
Schueler, A. and Gulba, D. and Sosada, M. and Ringe, B. and Pichlmayr, R. and Manns, M.
Fibrinolysis & Proteolysis 9 (Suppl:1): 129-132. 1 January 1995

Analysis of the human tissue-type plasminogen activator gene promoter activitor gene promoter activity during embryogenesis of transgenic mice and rats.
Theuring, F. and Aguzzi, A. and Turner, J.D. and Kropp, C. and Hoffmann, S. and Schleuning, W.D.
Fibrinolysis & Proteolysis 9 (5): 277-287. 1 January 1995

Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system.
Dechend, R. and Hauck, S. and Eichhorn, J. and Goedecke, W. and Praus, M. and Schulz-Menger, J. and Barthels, M. and Dietz, R. and Gulba, D.
Fibrinolysis & Proteolysis 8 Suppl. 2 : 71-74. 1 January 1994

Fragmentation pattern of fibrinogen during thrombolysis in acute myocardial infaction with fibrin-specific plasminogen activators - detection of high-molecular weight fibrinogen degradation products.
Dechend, R. and Thode, H. and Mueller, T. and Eisert, W.E. and Dietz, R. and Gulba, D.
Fibrinolysis & Proteolysis 8 Suppl. 2 : 102-104. 1 January 1994

Transgenic mice carrying a human t-PA promoter-lacZ reporter gene: A model for the study of pharmacological modulation of fibrinolytic potential.
Theuring, F. and Kooistra, T. and Schleuning, W.D.
Fibrinolysis & Proteolysis 8 : 16-18. 1 January 1994

Review

Thrombolytic agents - an updated overview.
Gulba, D.C. and Bode, C. and Runge, M.S. and Huber, K.
Fibrinolysis & Proteolysis 12 (Suppl 2): 39-58. 1 September 1998